Skip to main content
. 2020 Jul 6;105(9):e3307–e3315. doi: 10.1210/clinem/dgaa410

Table 2.

Baseline Characteristics of Patients With Adrenal Adenoma

DST <1.9 μg/dL DST = 1.9-5.0 μg/dL P value
N 275 168
Age, years; median (range) 59.5 (20.8-83.9) 66.1 (29.9-91.2) <0.001
Women, n (%) 167 (60.7) 113 (67.3) 0.166
DST, μg/dL; median (range) 1.2 (0.9-1.8) 2.6 (1.9-4.9)
ACTH, pg/mL; median (range)
Missing
14.0 (5.0-38.0)
207
10.5 (4.9-59.0)
116
0.066
DHEA-S, mcg/dL; median (range)
Missing
57.0 (1.9-538.0)
216
36.0 (14.0-223.0)
123
0.006
BMI, kg/m2; median (range)
BMI, n (%)
10-18.9
19-25.9
26-29.9
30+
Missing
32 (15-68)
2 (0.7)
39 (14.2)
63 (22.9)
171 (62.2)
0
31 (18-58)
2 (1.2)
35 (21.0)
41 (24.6)
89 (53.3)
1
0.041
0.202
Tumor size a, mm
Median (range)
Missing
17
(3-71)
3
26
(5-110)
1
<0.001
Duration of prior medical history, years
Median (range)
21.7 (1.0-42.2) 22.9 (1.0-40.7) 0.942
Smoke or other tobacco use, n(%)
Never
Former
Current
Missing
108 (41.2)
96 (36.6)
58 (22.1)
13
56 (36.4)
65 (42.2)
33 (21.4)
14
0.502
You/Others felt you needed to reduce alcohol consumption, n (%)
Missing
17 (6.9)
30
11 (7.0)
11
0.979
Elixhauser index b, sum (median, range)
Elixhauser, n (%)
0-1
2-4
5+
2 (0-17)
93 (33.8)
113 (41.1)
69 (25.1)
4 (0-15)
42 (25.0)
64 (38.1)
62 (36.9)
0.002
0.020

Abbreviations: ACTH, adrenocorticotropic hormone; BMI, body mass index; DHEA-S, dehydroepiandrosterone sulfate; DST, 1 mg dexamethasone suppression test.

aLarger diameter (if >1 tumor) on closest image to index date (median days from image to index was 18 days (IQR = 1 day to 87 days prior to index date; range -16 years-9 years after index date).

bElixhauser comorbidity index categorizes comorbidities of patients based on the International Classification of Diseases diagnosis codes; data within 5 years prior to the index date was used for this calculation.